Like the astronomical explosion that kickstarted the universe, bowel cancer has a "Big Bang" moment which determines how it ...

Tom Collins, research lead for discovery research at the Wellcome Trust, said: "Through tracing the earliest stages of bowel ...

Imunon is focusing TheraPlas on developing treatments for aggressive, hard-to-treat cancers, starting with ovarian. Its lead ...

CGI's profit was dented in the final three months of its fiscal year by acquisition and restructuring costs, though the Canadian information technology and software company raised its dividend payout.

Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic ...

Experts have finally uncovered a 'big bang' moment which determines how bowel cancer will grow, in landmark research ...

Columbia University received a major grant renewal from the National Institutes of Health to fund its comprehensive cancer ...

Experimental, drug-free, MRI-guided cancer treatment may one day offer a way of targeting and destroying pancreatic tumors ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors. Research reported recently in the journal Nature ...

By combining LED technology and nanomaterials, researchers have created a therapy that eliminates cancer cells using ...

NEW YORK – Azalea Therapeutics launched on Tuesday, having raised $82 million in seed and Series A financing to develop in vivo genetic medicines for cancer and autoimmune conditions using its ...

The firm is now offering combined ex vivo drug sensitivity and genomic testing to cancer patients outside the clinical trial setting.